Select Medical (NYSE:SEM) Downgraded to “Hold” Rating by StockNews.com

StockNews.com downgraded shares of Select Medical (NYSE:SEM) from a buy rating to a hold rating in a report released on Thursday morning.

Other analysts have also recently issued research reports about the company. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. UBS Group reduced their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Finally, Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $39.50.

Select Medical Trading Up 2.7 %

Shares of Select Medical stock opened at $18.74 on Thursday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a fifty day moving average of $19.25 and a 200 day moving average of $28.82. The company has a market capitalization of $2.43 billion, a P/E ratio of 8.75, a P/E/G ratio of 0.65 and a beta of 1.45. Select Medical has a fifty-two week low of $18.02 and a fifty-two week high of $40.98.

Insiders Place Their Bets

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Hedge Funds Weigh In On Select Medical

Large investors have recently modified their holdings of the stock. Quarry LP purchased a new position in Select Medical during the third quarter worth $30,000. Smartleaf Asset Management LLC boosted its stake in shares of Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider’s stock worth $43,000 after purchasing an additional 1,473 shares during the period. Wilmington Savings Fund Society FSB bought a new position in Select Medical during the 3rd quarter valued at about $81,000. Covestor Ltd raised its position in Select Medical by 33.5% in the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider’s stock worth $93,000 after purchasing an additional 1,244 shares during the period. Finally, Cibc World Markets Corp bought a new stake in Select Medical in the fourth quarter worth about $191,000. Institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.